Security key
71880W501
Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (PHIO)
CUSIP: 71880W501
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 12,067,869
- Total 13F shares
- 28,506
- Share change
- +28,506
- Total reported value
- $98,345
- Price per share
- $3.45
- Number of holders
- 6
- Value change
- +$98,345
- Number of buys
- 6
Report period
Q3 2024
Institutions
6
Top holders
6
PHIO full security history
Newer quarter: Q4 2024
Phio Pharmaceuticals Corp. SEC filings
Phio Pharmaceuticals Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71880W501
Recent filing periods:
Top shareholders of PHIO - Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Gerrit Dispersyn |
3/4/5
|
President & CEO, Director |
—
class O/S missing
|
212,327
|
$320,614 | — | 01 Mar 2022 | |
| H. Paul Dorman |
3/4/5
|
Director |
—
class O/S missing
|
20,370
|
$30,759 | — | 15 Feb 2022 | |
| Cetera Investment Advisers |
13F
|
Company |
—
class O/S missing
|
35,416
|
$24,504 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
28,136
|
$19,662 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
24,380
|
$16,869 | — | 30 Jun 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
23,486
|
$16,412 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
21,691
|
$15,158 | — | 30 Jun 2024 | |
| Caitlin Kontulis |
3/4/5
|
Secretary & VP Finance & Admin |
—
class O/S missing
|
10,643
|
$10,196 | — | 01 Mar 2024 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
—
class O/S missing
|
14,233
|
$10,000 | — | 30 Jun 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
—
class O/S missing
|
12,457
|
$8,619 | — | 30 Jun 2024 | |
| Robert M. Infarinato |
3/4/5
|
VP, CFO |
—
class O/S missing
|
11,000
|
$8,140 | — | 11 Sep 2024 | |
| Geert Cauwenbergh |
3/4/5
|
Director |
—
class O/S missing
|
4,235
|
$6,395 | — | 17 Feb 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
5,732
|
$3,967 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
2,447
|
$1,693 | — | 30 Jun 2024 | |
| Activest Wealth Management |
13F
|
Company |
—
class O/S missing
|
83
|
$57 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
38
|
$26 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
—
class O/S missing
|
1
|
$1 | — | 30 Jun 2024 |
Institutional Holders of Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (PHIO) as of Q3 2024
As of 30 Sep 2024,
Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (PHIO) was held by
6 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,506 shares.
The largest 6 holders included
SABBY MANAGEMENT, LLC, UBS Group AG, Tower Research Capital LLC (TRC), Nordwand Advisors, LLC, Activest Wealth Management, and BANK OF AMERICA CORP /DE/.
This page lists
6
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q4 2025 Across Filers
Q4 2025 holders
17
Q3 2024 holders
6
Holder diff
-11
| Investor | Q4 2025 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.